Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine

Conjugate Vaccines ◽

Infant Vaccination

Immunogenicity of a 2 + 1 Infant Vaccination Series with 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV): a Randomized Trial Exploring Interchangeability of PCVs

Open Forum Infectious Diseases ◽

10.1093/ofid/ofx163.1402 ◽

2017 ◽

Vol 4 (suppl_1) ◽

pp. S538-S539 ◽

Cited By ~ 1

Author(s):

Abiel Mascareñas De Los Santos ◽

Miguel Angel Rodríguez-Weber ◽

Pedro Sánchez-Márquez ◽

Roberto Carreño-Manjarrez ◽

María Yolanda Cervantes-Apolinar ◽

...

Keyword(s):

Haemophilus Influenzae ◽

Randomized Trial ◽

Conjugate Vaccine ◽

Infant Vaccination

Long-term Immune Responses to Pneumococcal Conjugate Vaccines in Children Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine

The Pediatric Infectious Disease Journal ◽

10.1097/inf.0b013e3182959f34 ◽

2013 ◽

Vol 32 (9) ◽

pp. 990-997 ◽

Cited By ~ 4

Author(s):

Nicola P. Klein ◽

Kathy Ensor ◽

Sylvie Jouve ◽

Robert Northington ◽

Michele Moscariello ◽

...

Keyword(s):

Immune Responses ◽

Conjugate Vaccine ◽

Conjugate Vaccines ◽

Changes in Hospitalizations for Pneumonia After Universal Vaccination With Pneumococcal Conjugate Vaccines 7/13 Valent and Haemophilus influenzae Type b Conjugate Vaccine in a Pediatric Referral Hospital in Uruguay

The Pediatric Infectious Disease Journal ◽

10.1097/inf.0000000000000294 ◽

2014 ◽

Vol 33 (7) ◽

pp. 753-759 ◽

Cited By ~ 32

Author(s):

María Catalina Pírez ◽

Gabriela Algorta ◽

Flavia Chamorro ◽

Claudia Romero ◽

Adriana Varela ◽

...

Keyword(s):

Haemophilus Influenzae ◽

Conjugate Vaccine ◽

Universal Vaccination ◽

Referral Hospital ◽

Haemophilus Influenzae Type ◽

Haemophilus Influenzae Type B ◽

Type B ◽

Conjugate Vaccines ◽

The Health Economic Impact of Universal Infant Vaccination with the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine as Compared with 13-Valent Pneumococcal Conjugate Vaccine in Hong Kong

Value in Health Regional Issues ◽

10.1016/j.vhri.2013.01.012 ◽

2013 ◽

Vol 2 (1) ◽

pp. 64-74 ◽

Cited By ~ 7

Author(s):

Kenneth K.C. Lee ◽

David Bin Chia Wu ◽

Oleksandr Topachevskyi ◽

Emmanuelle Delgleize ◽

Rodrigo DeAntonio

Keyword(s):

Health Economic ◽

Hong Kong ◽

Haemophilus Influenzae ◽

Economic Impact ◽

Conjugate Vaccine ◽

Nontypeable Haemophilus Influenzae ◽

Infant Vaccination ◽

Universal Infant

Recent Advances in Pneumococcal Conjugate Vaccines: A 13-Valent Pneumococcal Conjugate Vaccine

Çocuk Enfeksiyon Dergisi/Journal of Pediatric Infection ◽

10.5152/ced.2011.25 ◽

2011 ◽

Vol 5 (2) ◽

pp. 68-73 ◽

Cited By ~ 5

Author(s):

Mehmet Ceyhan

Keyword(s):

Conjugate Vaccine ◽

Conjugate Vaccines ◽

Recent Advances

Correction to: Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India

Infectious Diseases and Therapy ◽

10.1007/s40121-021-00526-3 ◽

2021 ◽

Author(s):

Canna J. Ghia ◽

Emily K. Horn ◽

Gautam Rambhad ◽

Johnna Perdrizet ◽

Ramaa Chitale ◽

...

Keyword(s):

Public Health ◽

Economic Impact ◽

Conjugate Vaccine ◽

Immunization Programs ◽

Conjugate Vaccines ◽

The Public

The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development

Vaccine ◽

10.1016/j.vaccine.2020.10.090 ◽

2020 ◽

Vol 38 (51) ◽

pp. 8068-8070

Author(s):

Andrew Vyse ◽

James Campling ◽

Carole Czudek ◽

Gillian Ellsbury ◽

Mary Slack

Keyword(s):

Conjugate Vaccine ◽

Invasive Pneumococcal Disease ◽

Pneumococcal Disease ◽

Pneumococcal Pneumonia ◽

Next Generation ◽

Conjugate Vaccines ◽

Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants

Clinical Infectious Diseases ◽

10.1093/cid/ciy743 ◽

2018 ◽

Vol 68 (9) ◽

pp. 1472-1481 ◽

Cited By ~ 7

Author(s):

William S Pomat ◽

Anita H J van den Biggelaar ◽

Sandra Wana ◽

Jacinta P Francis ◽

Vela Solomon ◽

...

Keyword(s):

Randomized Controlled Trial ◽

High Risk ◽

Conjugate Vaccine ◽

Controlled Trial ◽

High Risk Population ◽

Conjugate Vaccines ◽

Randomized Controlled ◽

Papua New Guinean

Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial

Vaccine ◽

10.1016/j.vaccine.2021.03.032 ◽

2021 ◽

Author(s):

J. Beissbarth ◽

N. Wilson ◽

B. Arrowsmith ◽

M.J. Binks ◽

V.M. Oguoma ◽

...

Keyword(s):

Randomised Controlled Trial ◽

Haemophilus Influenzae ◽

Otitis Media ◽

Conjugate Vaccine ◽

Controlled Trial ◽

Nasopharyngeal Carriage ◽

Randomised Controlled

Protein D of Haemophilus influenzae: A Protective Nontypeable H. influenzae Antigen and a Carrier for Pneumococcal Conjugate Vaccines

Clinical Infectious Diseases ◽

10.1086/527396 ◽

2008 ◽

Vol 46 (5) ◽

pp. 726-731 ◽

Cited By ~ 88

Author(s):

A. Forsgren ◽

K. Riesbeck

Keyword(s):

Haemophilus Influenzae ◽

Conjugate Vaccines ◽